Chronic Kidney Disease Clinical Trials in Palermo
2 recruitingPalermo, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled565 locationsNCT07241390
Recruiting
Not Applicable
Validation, Implementation, and Cost-analysis of a Strategy for Personalized Diagnosis of Rare Kidney Diseases
Chronic Kidney Diseases
Meyer Children's Hospital IRCCS300 enrolled3 locationsNCT06324136